ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00777699
Recruitment Status : Completed
First Posted : October 22, 2008
Last Update Posted : February 3, 2012
Sponsor:
Information provided by (Responsible Party):
Sanofi

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2011
  Actual Study Completion Date : February 2011